Diapositiva 1

1
NOT ALL PAST SUCCESSES IN CANCER RESEARCH HAVE
BEEN FOLLOWED BY ACTIONS EUROCHIP-2 THE
ACTION Project news
Public Health Program EUROPEAN COMMISSION HEALTH
CONSUMER PROTECTION DIRECTORATE - GENERAL
www.tumori.net/eurochip
2
WHAT IS THE EUROCHIP-2 THE ACTION PROJECT?

• It is a translational research project
  (from epidemiology to public
  health)
• It is a project against disparities
• It is an EC project
• It aims to research ways to promote health by EU
  imprimatur
• Its goal is to promote public health actions
  against cancer in each EU country
• It works in the building of an European platform
  for cancer control

3
EUROPE WITHIN THE WORLD
AGE-STANDARDIZED INCIDENCE RATES
Source GLOBOCAN 2002, IARC. Age-Standardised
(World) rates, per 100,000
4
EUROPE WITHIN THE WORLD
AGE-STANDARDIZED MORTALITY RATES
Source GLOBOCAN 2002, IARC. Age-Standardised
(World) rates, per 100,000
5
All cancers combined Europe
6
Differences in Europe. Relative risks (Max/Min).
All cancers combined
Year Males Females
Mortality 1985 2.3 1.8
Mortality 1996 4.3 1.9
Incidence 1985 1.9 1.9
Incidence 1996 1.9 2.2
5-yrs Survival 1985-89 2.2 2.0
5-yrs Survival 1990-94 2.5 2.0
Data from cancer registries of these
countries Austria, Bulgaria, Croatia, Czech
Republic, Denmark, Estonia, Finland, France,
Germany, Greece, Hungary, Iceland, Ireland,
Italy, Latvia, Lithuania, Luxembourg, Malta,
Netherlands, Norway, Poland, Portugal, Romania,
Slovakia, Slovenia, Spain, Sweden, Switzerland,
United Kingdom
Sources EUROCIM - EUROCARE
7
GDP (1997) and 5-year cancer survival
Disks are proportional to the national health
expenditure ( PPP) PPP Parity Purchasing
Power per capita (US ) Sourcesi OECD 2002 and
EUROCARE-3
8
EUROCHIP-1
INDICATOR A INDICATOR B INDICATOR
C . . . INDICATOR Z
INFORMATION
Data available
ANALYSIS
Inequalities
EUROCHIP-2
ACTIONS
9
GENERAL AIMS OF EUROCHIP-2

1. To extend the collaboration
2. To promote national groups in each country
3. To analyse the behaviour of available indicators
4. To discuss on deficiencies at national and
   international level
5. To promote at least one important ACTION in each
   country

10
EUROCHIP-2 MAP
11
EUROCHIP-2 DISCUSSION PLAN
COUNTRY 1
COUNTRY 2
COUNTRY 3
COUNTRY 30
ACTION 1
ACTION 2
ACTION 3
ACTION 3
ACTION 4
ACTION 4
ACTION 5
ACTION 6
ACTION 6
EUROPEAN PUBLIC HEALTH ACTION early
diagnosis Cervical screening
EUROPEAN PUBLIC HEALTH ACTION care treatment
Pilot studies
EUROPEAN PUBLIC HEALTH ACTION - prevention
Dietary prevention
EU CANCER PLAN
12
UTERUS CANCER STANDARDIZED MORTALITY RATE AGE 20
44 (IN THESE AGES MOSTLY CERVICAL CANCER)
European standard per 100,000
EARLY DIAGNOSIS
PILLAR 1
http//epicancer.iss.it
13
EUROCHIP-2 ACTION TASK FORCE ON CERVICAL CANCER
SCREENING AIMS
ACTION 1

• Describe the opportunistic/programmed cervical
  cancer screening in those countries at present
  time
• For countries without cervical screening
  programs find difficulties and problems with
  specific assessment studies in these Eastern
  European countries
• For countries with cervical screening programs
  to help specific activities that at the moment
  are not subsidize
• To create relations with groups of pressure with
  national health ministries and with European
  Parliament
• To share information with other networks (EUNICE,
  European Cancer Screening networks)

14
ASSESSMENT PHASES COLLECTION OF INFO ON
ROMANIA

• Use of Policies, Guidelines, and Norms
• Program Management Issues
• Health Services
• Information and Education Activities
• Community Perspectives
• Laboratory
• Information Systems

15
Screening prices VS treatment prices
BULGARIA

• In Bulgaria the mean value of programme screening
  for 1 person is around 5
• Target population 1.8 million (age 25-60)
• Screening interval 3 years
• 5 0.6 million 3 million per year

BULGARIAN ESTIMATES
Cervical cancer stages Number of cases in Bulgaria (2001) Prices according to EU data (Andrae Bengt - 2004) Prices according to EU data (Andrae Bengt - 2004)
Cervical cancer stages Number of cases in Bulgaria (2001) Per item Total
St. III IV 347 30 000 10 410 000
St. I II 670 9 000 6 030 000
CIS 275 300 83 500
Total 1292 - 16 522 500
V. Zlatkov - Bulgaria (2006)
16
PROBLEMS OF THE ORGANISED SCREENING PROGRAM
ESTONIA

• Low participation Only 21.7 of the 12,960
  invited women attended the screening
• No funds for screening registry
• No invitation of women without insurance (5 of
  population)

• To use experience from other countries to produce
  successful campaigns
• Group of pressure for invitation of women without
  insurance
• Money for starting the organization of screening
  registry

P. Veerus - Estonia (2006)
17
EUROCHIP FUND

• Budget 17.500 - Only for personnel costs
• Involvement of personnel for
  ACTIONS
• Money sent
• Directly to personnel OR
• To Institute involved in the project
• Necessary admin. documentation (at the end of the
  work)
• Declaration of money receipt (by personnel)
• Declaration of personnel payment (by Institute)

18
EUROCHIP-2 FUNDS THE ACTION IN LATVIA
19
(No Transcript)